Wu said that YZi Labs posted on the X platform, once again criticizing CEA Industries (BNC) for restricting shareholders' exercise of written consent rights through the introduction of a poison pill plan and amendments to the bylaws, believing that this move is aimed at strengthening the board's power rather than protecting shareholders' interests. YZi Labs also denied BNC's claim that they have never considered alternative tokens, pointing out that BNC CEO David Namdar explicitly stated at an industry conference in November 2025 that BNC had considered using other cryptocurrencies, such as Solana. YZi Labs calls on the board to avoid further manipulative actions and ensure that the nomination and election process of directors at the 2025 shareholders' meeting is fair and transparent. YZi Labs has submitted a preliminary consent statement to the U.S. Securities and Exchange Commission seeking to expand the BNC board of directors and elect its nominated directors.